{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:09:58Z","timestamp":1790226598094,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SNUH Research Fund","award":["26-20200030"],"award-info":[{"award-number":["26-20200030"]}]},{"name":"SNUH Kun-hee Lee Child Cancer & Rare Disease Project","award":["23C-027-0100"],"award-info":[{"award-number":["23C-027-0100"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["MSIT, 2019R1A2C209009911"],"award-info":[{"award-number":["MSIT, 2019R1A2C209009911"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12975-025-01384-8","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:13:34Z","timestamp":1759349614000},"page":"2232-2248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of Biomarkers Related to the Pathogenesis and Prognosis of Pediatric Moyamoya Disease Via Cerebrospinal Fluid Proteomics"],"prefix":"10.1007","volume":"16","author":[{"given":"Youngbo","family":"Shim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisoon","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saehim","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Phi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Whan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"1384_CR1","first-page":"37","volume":"9","author":"K Takeuchi","year":"1957","unstructured":"Takeuchi K. Hypoplasia of bilateral internal carotid arteries. No To Shinkei. 1957;9:37\u201343.","journal-title":"No To Shinkei"},{"key":"1384_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular, \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288\u201399.","journal-title":"Arch Neurol"},{"key":"1384_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.47.1","volume":"47","author":"Y Takagi","year":"2007","unstructured":"Takagi Y, Kikuta K, Nozaki K, Hashimoto N. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo). 2007;47:1\u20134.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1384_CR4","doi-asserted-by":"crossref","unstructured":"Derdeyn CPM, Pollak LM, Scott RMM, Smith ERM. Moyamoya disease and moyamoya syndrome. The New England Journal of Medicine. 2009;361:97-; author reply 8.","DOI":"10.1056\/NEJMc090780"},{"key":"1384_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.7150\/ijms.11719","volume":"12","author":"J Piao","year":"2015","unstructured":"Piao J, Wu W, Yang Z, Yu J. Research progress of Moyamoya disease in children. Int J Med Sci. 2015;12:566\u201375.","journal-title":"Int J Med Sci"},{"key":"1384_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fneur.2019.00014","volume":"10","author":"J Zheng","year":"2019","unstructured":"Zheng J, Yu LB, Dai KF, Zhang Y, Wang R, Zhang D. Clinical features, surgical treatment, and long-term outcome of a multicenter cohort of pediatric Moyamoya. Front Neurol. 2019;10:14.","journal-title":"Front Neurol"},{"key":"1384_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Bang JS, Kim JE, Cho WS. Moyamoya disease: treatment and outcomes. J Stroke. 2016;18:21\u201330.","journal-title":"J Stroke"},{"key":"1384_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/STROKEAHA.117.018563","volume":"49","author":"G Acker","year":"2018","unstructured":"Acker G, Fekonja L, Vajkoczy P. Surgical management of Moyamoya disease. Stroke. 2018;49:476\u201382.","journal-title":"Stroke"},{"key":"1384_CR9","first-page":"1073","volume":"31","author":"S Kuroda","year":"2003","unstructured":"Kuroda S, Nanba R, Ishikawa T, Houkin K, Kamiyama H, Iwasaki Y. [Clinical manifestations of infantile moyamoya disease]. No Shinkei Geka. 2003;31:1073\u20138.","journal-title":"No Shinkei Geka"},{"key":"1384_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6:e22542.","journal-title":"PLoS ONE"},{"key":"1384_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34\u201340.","journal-title":"J Hum Genet"},{"key":"1384_CR12","doi-asserted-by":"crossref","unstructured":"Shoemaker LD, Clark MJ, Patwardhan A, Chandratillake G, Garcia S, Chen R, et al. Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing. G3 (Bethesda). 2015;6:41\u20139.","DOI":"10.1534\/g3.115.020321"},{"key":"1384_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/TACG.S252736","volume":"14","author":"KB Dorschel","year":"2021","unstructured":"Dorschel KB, Wanebo JE. Genetic and proteomic contributions to the pathophysiology of Moyamoya angiopathy and related vascular diseases. Appl Clin Genet. 2021;14:145\u201371.","journal-title":"Appl Clin Genet"},{"key":"1384_CR14","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1161\/01.STR.0000100159.43123.D7","volume":"34","author":"SK Kim","year":"2003","unstructured":"Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, et al. Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke. 2003;34:2835\u201341.","journal-title":"Stroke"},{"key":"1384_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/092986608783330297","volume":"15","author":"S R\u00fcggeberg","year":"2008","unstructured":"R\u00fcggeberg S, Horn P, Li X, Vajkoczy P, Franz T. Detection of a gamma-carboxy-glutamate as novel post-translational modification of human transthyretin. Protein Pept Lett. 2008;15:43\u20136.","journal-title":"Protein Pept Lett"},{"key":"1384_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.028","volume":"24","author":"M Maruwaka","year":"2015","unstructured":"Maruwaka M, Yoshikawa K, Okamoto S, Araki Y, Sumitomo M, Kawamura A, et al. Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry. J Stroke Cerebrovasc Dis. 2015;24:104\u201311.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1384_CR17","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.028","volume":"26","author":"D Kashiwazaki","year":"2017","unstructured":"Kashiwazaki D, Uchino H, Kuroda S. Downregulation of apolipoprotein-E and apolipoprotein-J in Moyamoya disease-a proteome analysis of cerebrospinal fluid. J Stroke Cerebrovasc Dis. 2017;26:2981\u20137.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1384_CR18","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1212\/WNL.0000000000007819","volume":"93","author":"D Herv\u00e9","year":"2019","unstructured":"Herv\u00e9 D, Ibos-Aug\u00e9 N, Calvi\u00e8re L, Rogan C, Labeyrie MA, Guichard JP, et al. Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy. Neurology. 2019;93:e388\u201397.","journal-title":"Neurology"},{"issue":"D1","key":"1384_CR19","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u201352.","journal-title":"Nucleic Acids Res"},{"key":"1384_CR20","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1002\/pmic.201300091","volume":"13","author":"D Han","year":"2013","unstructured":"Han D, Moon S, Kim Y, Kim J, Jin J, Kim Y. In-depth proteomic analysis of mouse microglia using a combination of FASP and StageTip-based, high pH, reversed-phase fractionation. Proteomics. 2013;13:2984\u20138.","journal-title":"Proteomics"},{"key":"1384_CR21","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J. The maxquant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11:2301\u201319.","journal-title":"Nat Protoc"},{"key":"1384_CR22","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13:2513\u201326.","journal-title":"Mol Cell Proteomics"},{"key":"1384_CR23","doi-asserted-by":"crossref","unstructured":"Jang HN, Moon SJ, Jung KC, Kim SW, Kim H, Han D, et al. Mass spectrometry-based proteomic discovery of prognostic biomarkers in adrenal cortical carcinoma. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13153890"},{"key":"1384_CR24","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10:1794\u2013805.","journal-title":"J Proteome Res"},{"key":"1384_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731\u201340.","journal-title":"Nat Methods"},{"key":"1384_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523\u201330.","journal-title":"Bioinformatics"},{"issue":"D1","key":"1384_CR27","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312.","journal-title":"Nucleic Acids Res"},{"key":"1384_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"1384_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","volume":"31","author":"C von Mering","year":"2003","unstructured":"von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258\u201361.","journal-title":"Nucleic Acids Res"},{"key":"1384_CR30","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"1384_CR31","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"1384_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12859-019-3222-6","volume":"20","author":"L Guo","year":"2019","unstructured":"Guo L, Lin W, Zhang Y, Li W, Wang J. BEST: a web server for brain expression spatio-temporal pattern analysis. BMC Bioinformatics. 2019;20:632.","journal-title":"BMC Bioinformatics"},{"key":"1384_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37\u201353.","journal-title":"Neuron"},{"key":"1384_CR34","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3171\/2015.4.JNS142900","volume":"124","author":"EH Kim","year":"2016","unstructured":"Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, et al. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 2016;124:1221\u20137.","journal-title":"J Neurosurg"},{"key":"1384_CR35","doi-asserted-by":"crossref","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78:803\u201310.","DOI":"10.1212\/WNL.0b013e318249f71f"},{"key":"1384_CR36","doi-asserted-by":"crossref","unstructured":"Miyatake S, Touho H, Miyake N, Ohba C, Doi H, Saitsu H, et al. Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity. J Hum Genet. 2012;57:804\u20136.","DOI":"10.1038\/jhg.2012.105"},{"key":"1384_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40478-023-01698-4","volume":"12","author":"M Vervuurt","year":"2024","unstructured":"Vervuurt M, Schrader JM, de Kort AM, Kersten I, Wessels H, Klijn CJM, et al. Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients. Acta Neuropathol Commun. 2024;12:6.","journal-title":"Acta Neuropathol Commun"},{"key":"1384_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/jnnp-2013-305953","volume":"85","author":"JS Jeon","year":"2014","unstructured":"Jeon JS, Ahn JH, Moon YJ, Cho WS, Son YJ, Kim SK, et al. Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change. J Neurol Neurosurg Psychiatry. 2014;85:726\u201331.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1384_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, et al. A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst. 2017;4:60-72.e4.","journal-title":"Cell Syst"},{"key":"1384_CR40","doi-asserted-by":"crossref","DOI":"10.3171\/2021.9.FOCUS21433","volume":"51","author":"V Letchuman","year":"2021","unstructured":"Letchuman V, Ampie L, Mastorakos P, Raper DMS, Kellogg RT, Park MS. Experimental animal models for the study of moyamoya disease. Neurosurg Focus. 2021;51:E4.","journal-title":"Neurosurg Focus"},{"key":"1384_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001862","author":"Y Moteki","year":"2015","unstructured":"Moteki Y, Onda H, Kasuya H, Yoneyama T, Okada Y, Hirota K, et al. Systematic validation of RNF213 coding variants in Japanese patients with Moyamoya disease. J Am Heart Assoc. 2015. https:\/\/doi.org\/10.1161\/JAHA.115.001862.","journal-title":"J Am Heart Assoc"},{"key":"1384_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/092986732304160204181543","volume":"23","author":"G Bedini","year":"2016","unstructured":"Bedini G, Blecharz KG, Nava S, Vajkoczy P, Alessandri G, Ranieri M, et al. Vasculogenic and angiogenic pathways in Moyamoya disease. Curr Med Chem. 2016;23:315\u201345.","journal-title":"Curr Med Chem"},{"key":"1384_CR43","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1161\/01.STR.28.9.1733","volume":"28","author":"M Yamamoto","year":"1997","unstructured":"Yamamoto M, Aoyagi M, Tajima S, Wachi H, Fukai N, Matsushima Y, et al. Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease. Stroke. 1997;28:1733\u20138.","journal-title":"Stroke"},{"key":"1384_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/GIM.0b013e3181cdd687","volume":"12","author":"DM Milewicz","year":"2010","unstructured":"Milewicz DM, Kwartler CS, Papke CL, Regalado ES, Cao J, Reid AJ. Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy. Genet Med. 2010;12:196\u2013203.","journal-title":"Genet Med"},{"key":"1384_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3892\/ijmm.2014.1853","volume":"34","author":"X Yu","year":"2014","unstructured":"Yu X, Li Z. Micrornas regulate vascular smooth muscle cell functions in atherosclerosis (review). Int J Mol Med. 2014;34:923\u201333.","journal-title":"Int J Mol Med"},{"key":"1384_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J. TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol. 2012;13:616\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1384_CR47","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1161\/STROKEAHA.123.044476","volume":"54","author":"S He","year":"2023","unstructured":"He S, Zhang J, Liu Z, Wang Y, Hao X, Wang X, et al. Upregulated cytoskeletal proteins promote pathological angiogenesis in Moyamoya disease. Stroke. 2023;54:3153\u201364.","journal-title":"Stroke"},{"key":"1384_CR48","first-page":"71","volume":"632","author":"U Amara","year":"2008","unstructured":"Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, Gebhard F, et al. Interaction between the coagulation and complement system. Adv Exp Med Biol. 2008;632:71\u20139.","journal-title":"Adv Exp Med Biol"},{"key":"1384_CR49","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.2741\/2419","volume":"12","author":"R Oksjoki","year":"2007","unstructured":"Oksjoki R, Kovanen PT, Meri S, Pentikainen MO. Function and regulation of the complement system in cardiovascular diseases. Front Biosci. 2007;12:4696\u2013708.","journal-title":"Front Biosci"},{"key":"1384_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094675","author":"K Ziabska","year":"2021","unstructured":"Ziabska K, Ziemka-Nalecz M, Pawelec P, Sypecka J, Zalewska T. Aberrant complement system activation in neurological disorders. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094675.","journal-title":"Int J Mol Sci"},{"key":"1384_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3340\/jkns.2010.48.1.8","volume":"48","author":"EJ Koh","year":"2010","unstructured":"Koh EJ, Kim HN, Ma TZ, Choi HY, Kwak YG. Comparative analysis of serum proteomes of moyamoya disease and normal controls. J Korean Neurosurg Soc. 2010;48:8\u201313.","journal-title":"J Korean Neurosurg Soc"},{"key":"1384_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jpeds.2009.10.034","volume":"156","author":"TJ Bernard","year":"2010","unstructured":"Bernard TJ, Fenton LZ, Apkon SD, Boada R, Wilkening GN, Wilkinson CC, et al. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke. J Pediatr. 2010;156:651\u20136.","journal-title":"J Pediatr"},{"key":"1384_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","volume":"184","author":"H Reiber","year":"2001","unstructured":"Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184:101\u201322.","journal-title":"J Neurol Sci"},{"key":"1384_CR54","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1742-2094-9-188","volume":"9","author":"V Pisani","year":"2012","unstructured":"Pisani V, Stefani A, Pierantozzi M, Natoli S, Stanzione P, Franciotta D, et al. Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson\u2019s disease. J Neuroinflammation. 2012;9:188.","journal-title":"J Neuroinflammation"},{"key":"1384_CR55","doi-asserted-by":"publisher","first-page":"27343","DOI":"10.1038\/srep27343","volume":"6","author":"F Beaubien","year":"2016","unstructured":"Beaubien F, Raja R, Kennedy TE, Fournier AE, Cloutier JF. Slitrk1 is localized to excitatory synapses and promotes their development. Sci Rep. 2016;6:27343.","journal-title":"Sci Rep"},{"key":"1384_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1044-7431(03)00129-5","volume":"24","author":"J Aruga","year":"2003","unstructured":"Aruga J, Mikoshiba K. Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol Cell Neurosci. 2003;24:117\u201329.","journal-title":"Mol Cell Neurosci"},{"key":"1384_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-025-01128-8","volume":"32","author":"B Aksan","year":"2025","unstructured":"Aksan B, Mauceri D. Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure. J Biomed Sci. 2025;32:33.","journal-title":"J Biomed Sci"},{"key":"1384_CR58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jbiosc.2025.05.010","volume":"140","author":"T Asaba","year":"2025","unstructured":"Asaba T, Osaki T, Murayama K, Hamano S, Kageyama T, Fukuda J. Effects of vascular endothelial cells on the neurite outgrowth of nerve cells. J Biosci Bioeng. 2025;140:168\u201373.","journal-title":"J Biosci Bioeng"},{"key":"1384_CR59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbrc.2014.06.012","volume":"450","author":"S Sumimoto","year":"2014","unstructured":"Sumimoto S, Muramatsu R, Fujii S, Yamashita T. Vascular endothelial cells promote cortical neurite outgrowth via an integrin \u03b23-dependent mechanism. Biochem Biophys Res Commun. 2014;450:593\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1384_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85129-1","volume":"11","author":"LN Manganas","year":"2021","unstructured":"Manganas LN, Dur\u00e1 I, Osenberg S, Semerci F, Tosun M, Mishra R, et al. BASP1 labels neural stem cells in the neurogenic niches of mammalian brain. Sci Rep. 2021;11:5546.","journal-title":"Sci Rep"},{"key":"1384_CR61","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/jdi.13920","volume":"14","author":"F Sun","year":"2023","unstructured":"Sun F, Liu J, Wang Y, Yang H, Song D, Fu H, et al. BASP1 promotes high glucose-induced endothelial apoptosis in diabetes via activation of EGFR signaling. J Diabetes Investig. 2023;14:535\u201347.","journal-title":"J Diabetes Investig"},{"key":"1384_CR62","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1021\/bi00311a010","volume":"23","author":"JW Burgner 2nd","year":"1984","unstructured":"Burgner JW 2nd, Ray WJ Jr. On the origin of the lactate dehydrogenase induced rate effect. Biochemistry. 1984;23:3636\u201348.","journal-title":"Biochemistry"},{"key":"1384_CR63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2017.08.041","volume":"492","author":"JH Kim","year":"2017","unstructured":"Kim JH, Bae KH, Byun JK, Lee S, Kim JG, Lee IK, et al. Lactate dehydrogenase-A is indispensable for vascular smooth muscle cell proliferation and migration. Biochem Biophys Res Commun. 2017;492:41\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1384_CR64","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3389\/fimmu.2018.02316","volume":"9","author":"C Brosseau","year":"2018","unstructured":"Brosseau C, Colas L, Magnan A, Brouard S. CD9 tetraspanin: a new pathway for the regulation of inflammation? Front Immunol. 2018;9:2316.","journal-title":"Front Immunol"},{"key":"1384_CR65","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1161\/01.ATV.20.2.360","volume":"20","author":"C Klein-Soyer","year":"2000","unstructured":"Klein-Soyer C, Azorsa DO, Cazenave JP, Lanza F. Cd9 participates in endothelial cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol. 2000;20:360\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1384_CR66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2011.08.068","volume":"413","author":"T Kamisasanuki","year":"2011","unstructured":"Kamisasanuki T, Tokushige S, Terasaki H, Khai NC, Wang Y, Sakamoto T, et al. Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Biochem Biophys Res Commun. 2011;413:128\u201335.","journal-title":"Biochem Biophys Res Commun"},{"key":"1384_CR67","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jash.2017.04.010","volume":"11","author":"A Randell","year":"2017","unstructured":"Randell A, Daneshtalab N. Elastin microfibril interface-located protein 1, transforming growth factor beta, and implications on cardiovascular complications. J Am Soc Hypertens. 2017;11:437\u201348.","journal-title":"J Am Soc Hypertens"},{"key":"1384_CR68","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/cvr\/cvp395","volume":"86","author":"N Daneshtalab","year":"2010","unstructured":"Daneshtalab N, Smeda JS. Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke. Cardiovasc Res. 2010;86:160\u20138.","journal-title":"Cardiovasc Res"},{"key":"1384_CR69","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/acn3.52076","volume":"11","author":"G Gorla","year":"2024","unstructured":"Gorla G, Potenza A, Carrozzini T, Pollaci G, Acerbi F, Vetrano IG, et al. Angiopoietin-2 associates with poor prognosis in Moyamoya angiopathy. Ann Clin Transl Neurol. 2024;11:1590\u2013603.","journal-title":"Ann Clin Transl Neurol"},{"key":"1384_CR70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13062-024-00522-w","volume":"19","author":"D Guo","year":"2024","unstructured":"Guo D, Dong Y, Li H, Li H, Yang B. Proteomics and digital subtraction angiography approaches reveal CDH18 as a potential target for therapy of moyamoya disease. Biol Direct. 2024;19:76.","journal-title":"Biol Direct"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-025-01384-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:03:08Z","timestamp":1762632188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-025-01384-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1007\/s12975-025-01384-8","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study was approved by the Institutional Review Board of our institute (No. 2011-191-1178) and informed consent was waived due to the retrospective study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}